美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Braveheart Bio

20.36

+0.34001.70%

成交量：15.51万

成交额：314.63万

市值：18.33亿

市盈率：-1.39

高：20.78

开：20.17

低：19.22

收：20.02

52周最高：32.00

52周最低：17.86

股本：9,003.90万

流通股本：2,583.17万

量比：0.32

换手率：0.60%

股息：- -

股息率：- -

每股收益(TTM):-14.6845

每股收益(LYR):-17.2003

净资产收益率：--

总资产收益率：--

市净率：-19.11

市盈率(LYR):-1.18

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

美国研究综述-Adobe、Braveheart Bio、CACI International

新闻稿：Braveheart Bio 宣布扩大规模首次公开募股完成，并完全行使承销商超额配股权

市场快讯——美股行情动态-Braveheart Bio、Paysign、Hertz Global

异动解读 | IPO首日表现强劲，Braveheart Bio盘中大涨67.78%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/BRVE"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BRVE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRVE\",,,,,undefined,":{"symbol":"BRVE","market":"US","secType":"STK","nameCN":"Braveheart Bio","latestPrice":20.36,"timestamp":1791835200000,"preClose":20.02,"halted":0,"volume":155072,"delay":0,"changeRate":0.016983016983016977,"floatShares":25831738,"shares":90039000,"eps":-14.684527,"marketStatus":"盘前交易","change":0.34,"latestTime":"10-13 05:05:30 EDT","open":20.17,"high":20.78,"low":19.219,"amount":3146308,"amplitude":0.077972,"askPrice":22.46,"askSize":100,"bidPrice":16.82,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-14.684527,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791898200000},"marketStatusCode":1,"adr":0,"listingDate":1785988800000,"exchange":"NASDAQ","adjPreClose":20.36,"postHourTrading":{"tag":"盘后","latestPrice":20.25,"preClose":20.36,"latestTime":"16:26 EDT","volume":9450,"amount":192376.66,"timestamp":1791836780624,"change":-0.11,"changeRate":-0.005403,"amplitude":0.005403},"volumeRatio":0.3151043729827761},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRVE\",,,,,undefined,":{"symbol":"BRVE","floatShares":25831738,"roa":"--","roe":"--","lyrEps":-17.200311,"volumeRatio":0.3151043729827761,"shares":90039000,"dividePrice":0,"high":20.78,"amplitude":0.077972,"preClose":20.02,"low":19.219,"week52Low":17.86,"pbRate":"-19.11","week52High":32,"institutionHeld":0,"latestPrice":20.36,"eps":-14.684527,"divideRate":0,"volume":155072,"delay":0,"ttmEps":-14.684527,"open":20.17,"prevYearClose":18,"prevWeekClose":20.02,"prevMonthClose":20.2,"prevQuarterClose":20.2,"fiveDayClose":21.35,"twentyDayClose":27.02,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BRVE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BRVE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BRVE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1789099200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BRVE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BRVE","date":"2026-10-12","current":-1.386493,"percent":0.723404,"low":-23.993466,"twenty":-22.008406,"median":-19.658668,"eighty":-16.265628,"high":-12.297967,"avg":-19.216044,"sd":2.96242,"marketCap":1634252980},"quantilePoints":[{"date":"2026-08-07","current":-22.904964,"twenty":-19.277064,"median":-13.835213,"eighty":-12.912865,"marketCap":1837733965},{"date":"2026-08-14","current":-20.770344,"twenty":-22.55018,"median":-20.842324,"eighty":-16.302149,"marketCap":1666466982},{"date":"2026-08-21","current":-21.930028,"twenty":-22.591769,"median":-21.618113,"eighty":-20.309669,"marketCap":1759511923},{"date":"2026-08-28","current":-22.281932,"twenty":-22.249941,"median":-22.006007,"eighty":-20.827928,"marketCap":1787746250},{"date":"2026-09-04","current":-21.010278,"twenty":-22.169963,"median":-21.930028,"eighty":-20.827928,"marketCap":1685717659},{"date":"2026-09-11","current":-18.437402,"twenty":-22.185958,"median":-21.618113,"eighty":-20.469626,"marketCap":1748603206},{"date":"2026-09-18","current":-18.748639,"twenty":-22.118777,"median":-21.390175,"eighty":-18.607905,"marketCap":1778120911},{"date":"2026-09-25","current":-16.155238,"twenty":-22.096383,"median":-21.010278,"eighty":-18.113986,"marketCap":1532162790},{"date":"2026-10-02","current":-18.612348,"twenty":-22.049995,"median":-20.582395,"eighty":-16.309906,"marketCap":1765195108},{"date":"2026-10-09","current":-16.431212,"twenty":-22.013205,"median":-19.756776,"eighty":-16.210433,"marketCap":1558336133},{"date":"2026-10-12","current":-17.231685,"twenty":-22.008406,"median":-19.658668,"eighty":-16.265628,"marketCap":1634252980}],"updateTime":1791882330305},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BRVE\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663002003","title":"美国研究综述-Adobe、Braveheart Bio、CACI International","url":"https://stock-news.laohu8.com/highlight/detail?id=2663002003","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663002003?lang=zh_cn&edition=fundamental","pubTime":"2026-08-31 15:24","pubTimestamp":1788161080,"startTime":"0","endTime":"0","summary":"美国研究综述-Adobe、Braveheart Bio、CACI International路透8月31日-周一，华尔街证券分析师上调了包括Adobe、Braveheart Bio和CACI International在内的几家美国上市公司的评级和目标股价。重点摘要* Adobe IncADBE.O：杰富瑞将目标价从230美元上调至285美元* Braveheart Bio, Inc.BRVE.O：杰富瑞首次覆盖该股，给予“买入”评级* CACI International IncCACI.N：TD Cowen将目标价从550美元上调至700美元以下是路透周一报道的关于美国公司的研究动态摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4S44S0JC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPS","LU2237957902.USD","LU0345774391.USD","LU1674673691.USD","LU2095319765.USD","LU1623119135.USD","LU0109392836.USD","LU0965509010.AUD","LU1803068979.SGD","PSWD","SG9999015952.SGD","LU0157215616.USD","LU0708995401.HKD","HONG","LU1815333072.USD","SG9999015978.USD","BK4007","LU2106854487.HKD","IE0031619046.USD","SG9999001424.SGD","LU0256863902.USD","LU2065731478.USD","IE00BQXX3C00.GBP","BK4550","LU0942090050.USD","LU0081259029.USD","LU2286300806.USD","LU0348723411.USD","LU0963586101.USD","LU1153585028.USD","SGXZ51526630.SGD","LU0861579265.USD","LU0198837287.USD","LU1084165304.USD","SGXZ23171101.USD","HON","LU2237957811.SGD","LU0289961442.SGD","LU0069063385.USD","BK4533","BK4504","BK4112","LU0949170772.SGD","LU0889566641.SGD","LU1169589451.USD","BK4212","LU1201861249.SGD","LU0965509101.SGD","LU1035773651.USD","LU0106261372.USD","SG9999000418.SGD","LU0124676726.USD","LU1235294995.USD","BK4139","BK4155","IE0009356076.USD","LU0082616367.USD","LU0683600562.USD","IE00BYQQ9H92.USD","LU0738911758.USD","LU1720051017.SGD","BK4527","LU0006061336.USD","LU1878469433.USD","IE00B66KJ199.SGD","PTGX","LU0162691827.USD","LU0868494617.USD","LU2125154935.USD","LU2357305700.SGD","LU1069347547.HKD","LU0345774631.USD","BRCC","IE00B19Z4B17.USD","ADBU","BK4528","LU0154236417.USD","BK4023","LU0957791311.USD","LU2023251221.USD","LU2360032135.SGD","LU1046421795.USD","BK4187","LU1823568750.SGD","BK4566","LU0661504455.SGD","LU0061474960.USD","LU0965509283.SGD","LU1267930813.SGD","LU0234572021.USD","LU1917777945.USD","BK4006","LU0314106906.USD","LU0792757196.USD","LU1506573853.SGD","BK4114","LU2236285917.USD","LU1119994496.HKD","BK4554","IE0034235188.USD","LU0472753341.HKD","IE00BQXX3D17.EUR","LU0689626769.HKD","LU0256863811.USD","LU0011850046.USD","BK4602","LU2125154778.USD","BK4567","LU0109391861.USD","LU1691799644.USD","BK4206","LU0072461881.USD","LU1712237335.SGD","BK4592","SPAM","LU0158827948.USD","BCDF","ADBG","LU0057025933.USD","LU0889565833.HKD","LU2210150020.SGD","LU0130102774.USD","LU1974910355.USD","LU2458330169.SGD","LU0234570918.USD","IE00B5TLWC47.USD","LU0154245756.USD","LU0289739343.SGD","LU0130517989.USD","LU0719512351.SGD","LU0511384066.AUD","GB00BDT5M118.USD","LU1674673428.USD","LU0342679015.USD","LU0868494708.USD","BK4585","LU0980610538.SGD","LU0170899867.USD","SG9999015986.USD","LU1267930730.SGD","ADBE","IE00BFXG0V08.USD","LU0006306889.USD","LU2237438978.USD","LU2089284900.SGD","LU2023250843.SGD","LU2317271919.USD","LU0787776722.HKD","LU2458330243.SGD","LU1548497426.USD","BK4613","IE00BQXX3F31.USD","LU0477156953.USD","RBRK","BK4543","LU0672654240.SGD","LU0971096721.USD","BK4123","BK4097","LU1169590202.USD","LU2023250504.SGD","LU1363072403.SGD","IE00B1BXHZ80.USD","LU0557290698.USD","LU1720051108.HKD","LU1778281490.HKD","LU0390134368.USD","LU1633808545.USD","IE00B7SZL793.SGD","BK4588","LU0154245673.USD","LU1366333091.USD","ICE","LU0417517546.SGD","LU2210149790.SGD","CACI","LU2247934214.USD","LU1261432733.SGD","SGXZ99366536.SGD","ATI","SG9999004303.SGD","SG9999015945.SGD","DLTR","LU0648001328.SGD","LU0054578231.USD","LU0314104364.USD","SGXZ81514606.USD","LU0320765059.SGD","BK4581","LU2089283258.USD","IE00B19Z9505.USD","BRVE","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171302218","title":"新闻稿：Braveheart Bio 宣布扩大规模首次公开募股完成，并完全行使承销商超额配股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1171302218","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171302218?lang=zh_cn&edition=fundamental","pubTime":"2026-08-08 04:09","pubTimestamp":1786133340,"startTime":"0","endTime":"0","summary":"旧金山，2026年8月7日——Braveheart Bio, Inc.是一家临床阶段的生物制药公司，致力于开发针对肥厚型心肌病及其他严重心血管疾病的下一代疗法。该公司今日宣布，其扩大的首次公开募股已完成。此次发行总计24,437,500股普通股，每股发行价为18.00美元，且承销商已完全行使了购买额外3,187,500股的选择权。所有普通股均由Braveheart Bio提供。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","BK4149","LU0689626769.HKD","LU0154245756.USD","LU0511384066.AUD","BK4588","IPOS","LU0289739343.SGD","LU0154245673.USD","BK4531","LU0472753341.HKD","LU2463526074.USD","LU0069063385.USD","LU0057025933.USD","LU0203345920.USD","BK4533","LU0203347892.USD","CMI","BK4567","BRVE","HCM","LU0124676726.USD","MADE","LU0289961442.SGD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657597666","title":"市场快讯——美股行情动态-Braveheart Bio、Paysign、Hertz Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2657597666","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657597666?lang=zh_cn&edition=fundamental","pubTime":"2026-08-07 01:45","pubTimestamp":1786038322,"startTime":"0","endTime":"0","summary":".N美国东部时间13:30，道琼斯工业平均指数.DJI下跌0.85%，报53,886.07点；标普500指数.SPX下跌0.28%，报7,701.81点；纳斯达克综合指数.IXIC下跌0.10%，报26,337.82点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL4T44328R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMR","IOVA","ZTS","EPAM","CHYM","PZZA","RL","VCTR","SRE","FRT","RCBC","GBFH","KVUE","HWM","KDP","NVAX","FIG","SPCX","U","WDC","MRNA","VTRS","RXO","CEG","RDVT","ROOT","TPG","PH","PRMB","CELH","UWMC","LNG","SRRK","SITM","HTZ","APP","BRVE","SNDK","MAC","PAYC","FOUR","MTSI","BDX","BLLN","INSM","LCLN","FISV","DDOG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1138238457","title":"异动解读 | IPO首日表现强劲，Braveheart Bio盘中大涨67.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138238457","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138238457?lang=zh_cn&edition=fundamental","pubTime":"2026-08-07 00:52","pubTimestamp":1786035174,"startTime":"0","endTime":"0","summary":"心血管药物开发商Braveheart Bio今日在纳斯达克首日上市交易，盘中股价大涨67.78%，引发市场广泛关注。Braveheart Bio总部位于加州旧金山，是一家处于临床后期的生物制药公司，专注于开发肥厚型心肌病及其他严重心血管疾病的创新疗法。在2026年生物科技IPO热潮的背景下，Braveheart Bio的成功上市进一步彰显了市场对创新药企的强劲信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BRVE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BRVE\",params:#limit:6,delay:false,,,undefined,":[]}}